128 related articles for article (PubMed ID: 8643367)
21. HIV-1 Exploits a Dynamic Multi-aminoacyl-tRNA Synthetase Complex To Enhance Viral Replication.
Duchon AA; St Gelais C; Titkemeier N; Hatterschide J; Wu L; Musier-Forsyth K
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814526
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes.
Macejak DG; Jensen KL; Jamison SF; Domenico K; Roberts EC; Chaudhary N; von Carlowitz I; Bellon L; Tong MJ; Conrad A; Pavco PA; Blatt LM
Hepatology; 2000 Mar; 31(3):769-76. PubMed ID: 10706571
[TBL] [Abstract][Full Text] [Related]
23. Design, characterization and testing of tRNA3Lys-based hammerhead ribozymes.
Medina MF; Joshi S
Nucleic Acids Res; 1999 Apr; 27(7):1698-708. PubMed ID: 10076002
[TBL] [Abstract][Full Text] [Related]
24. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR.
Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
Nucleic Acids Symp Ser; 1995; (34):125-6. PubMed ID: 8841584
[TBL] [Abstract][Full Text] [Related]
25. Methods for analysis of incorporation and annealing methods for analysis of tRNA(Lys) in HIV-1.
Cen S; Guo F; Kleiman L
Methods Mol Biol; 2009; 485():223-32. PubMed ID: 19020829
[TBL] [Abstract][Full Text] [Related]
26. Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis.
Paik SY; Banerjea A; Chen CJ; Ye Z; Harmison GG; Schubert M
Hum Gene Ther; 1997 Jun; 8(9):1115-24. PubMed ID: 9189769
[TBL] [Abstract][Full Text] [Related]
27. Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes.
Miller JT; Khvorova A; Scaringe SA; Le Grice SF
Nucleic Acids Res; 2004; 32(15):4687-95. PubMed ID: 15342789
[TBL] [Abstract][Full Text] [Related]
28. Analysis of murine leukemia virus replication complemented by yeast tRNA(Phe) reveals inherent preferences for the tRNA primer selected for reverse transcription.
Palmer MT; Morrow CD
Virology; 2004 Jul; 324(2):430-8. PubMed ID: 15207628
[TBL] [Abstract][Full Text] [Related]
29. The selective packaging and annealing of primer tRNALys3 in HIV-1.
Kleiman L; Halwani R; Javanbakht H
Curr HIV Res; 2004 Apr; 2(2):163-75. PubMed ID: 15078180
[TBL] [Abstract][Full Text] [Related]
30. Use of a nonviral vector to express a chimeric tRNA-ribozyme against lymphocytic choriomeningitis virus: cytoplasmic accumulation of a catalytically competent transcript but minimal antiviral effect.
Gebhard JR; Perry CM; Mahadeviah S; Whitton JL
Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):3-11. PubMed ID: 9055033
[TBL] [Abstract][Full Text] [Related]
31. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
Zhou C; Bahner I; Rossi JJ; Kohn DB
Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
[TBL] [Abstract][Full Text] [Related]
32. tRNA Lys3 promoter cassettes that efficiently express RNAi-activating antihepatitis B virus short hairpin RNAs.
Dyer V; Ely A; Bloom K; Weinberg M; Arbuthnot P
Biochem Biophys Res Commun; 2010 Aug; 398(4):640-6. PubMed ID: 20599752
[TBL] [Abstract][Full Text] [Related]
33. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line.
Michienzi A; Conti L; Varano B; Prislei S; Gessani S; Bozzoni I
Hum Gene Ther; 1998 Mar; 9(5):621-8. PubMed ID: 9551610
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HIV type 1 replication using lentiviral-mediated delivery of mutant tRNA(Lys3)A58U.
Renda MJ; Bradel-Tretheway B; Planelles V; Bambara RA; Dewhurst S
AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1324-34. PubMed ID: 15650425
[TBL] [Abstract][Full Text] [Related]
36. Multiple site-specific cleavage of HIV RNA by transcribed ribozymes from shotgun-type trimming plasmid.
Ohkawa J; Yuyama N; Takebe Y; Nisikawa S; Homann M; Sczakiel G; Taira K
Nucleic Acids Symp Ser; 1993; (29):121-2. PubMed ID: 8247732
[TBL] [Abstract][Full Text] [Related]
37. New insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3.
Wu C; Nerurkar VR; Lu Y
Retrovirology; 2013 Oct; 10():112. PubMed ID: 24156557
[TBL] [Abstract][Full Text] [Related]
38. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1.
Yamada O; Kraus G; Luznik L; Yu M; Wong-Staal F
J Virol; 1996 Mar; 70(3):1596-601. PubMed ID: 8627679
[TBL] [Abstract][Full Text] [Related]
39. Interactions with tRNA(Lys) induce important structural changes in human immunodeficiency virus reverse transcriptase.
Robert D; Sallafranque-Andreola ML; Bordier B; Sarih-Cottin L; Tarrago-Litvak L; Graves PV; Barr PJ; Fournier M; Litvak S
FEBS Lett; 1990 Dec; 277(1-2):239-42. PubMed ID: 1702735
[TBL] [Abstract][Full Text] [Related]
40. Specific inhibition of the synthesis of human lysyl-tRNA synthetase results in decreases in tRNA(Lys) incorporation, tRNA(3)(Lys) annealing to viral RNA, and viral infectivity in human immunodeficiency virus type 1.
Guo F; Cen S; Niu M; Javanbakht H; Kleiman L
J Virol; 2003 Sep; 77(18):9817-22. PubMed ID: 12941890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
